Cited by 217Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: Who is really at risk?

Open access
Daan, Nadine M.P., Louwers, Yvonne V., Koster, Maria P.H., Eijkemans, Marinus J.C., de Rijke, Yolanda B., Lentjes, Eef W.G., Fauser, Bart C.J.M., Laven, Joop S.E.·2014·Fertility and Sterility

Abstract

Objective To study the cardiometabolic profile characteristics and compare the prevalence of cardiovascular (CV) risk factors between women with different polycystic ovary syndrome (PCOS) phenotypes.Design A cross-sectional multicenter study analyzing 2,288 well phenotyped women with PCOS.Setting Specialized reproductive outpatient clinic.Patient(s) Women of reproductive age (18-45 years) diagnosed with PCOS.Intervention(s) Women suspected of oligo- or anovulation underwent a standardized screening consisting of a systematic medical and reproductive history taking, anthropometric measurements, and transvaginal ultrasonography followed by an extensive endocrinologic/metabolic evaluation.Main outcome measure(s) Differences in cardiometabolic profile characteristics and CV risk factor prevalence between women with different PCOS phenotypes, i.e., obesity/overweight, hypertension, insulin resistance, dyslipidemia, and metabolic syndrome.Result(s) Women with hyperandrogenic PCOS (n=1,219; 53.3% of total) presented with a worse cardiometabolic profile and a higher prevalence of CV risk factors, such as obesity and overweight, insulin resistance, and metabolic syndrome, compared with women with nonhyperandrogenic PCOS. In women with nonhyperandrogenic PCOS overweight/obesity (28.5%) and dyslipidemia (low-density lipoprotein cholesterol≥3.0 mmol/L; 52.2%) were highly prevalent.Conclusion(s) Women with hyperandrogenic PCOS have a worse cardiometabolic profile and higher prevalence of CV risk factors compared with women with nonhyperandrogenic PCOS. However, all women with PCOS should be screened for the presence of CV risk factors, since the frequently found derangements at a young age imply an elevated risk for the development of CV disease later in life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2014.08.001

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; to- ward a rational approach. In: Dunaif A, Givens JR, Haseltine FP, editors. Poly- cystic ovary syndrome. Boston: Blackwell Scientific; 1992:377-84.

Cited by

Sorted by citations

Authors
Daan, N. M. P., Louwers, Y. V., Koster, M. P. H., Eijkemans, M. J. C., de Rijke, Y. B., Lentjes, E. W. G., Fauser, B. C. J. M., & Laven, J. S. E.
Affiliations
  • University Medical Center Utrecht (NL)
  • Erasmus MC (NL)
Corresponding author
Daan, Nadine M.P.
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2014-11
Volume
102
Issue
5
Pages
1444-1451.e3
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2110503690
Cited by
217
References
50
Citations by year
2026: 20 · 2025: 16 · 2024: 21 · 2023: 17 · 2022: 13 · 2021: 19 · 2020: 17 · 2019: 21 · 2018: 17 · 2017: 21 · 2016: 16 · 2015: 19
FWCI
22.62
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
polycystic ovary syndrome, PCOS phenotypes, hyperandrogenism, cardiometabolic profile, cardiovascular risk factors, obesity, insulin resistance, metabolic syndrome, dyslipidemia, hypertension
MeSH terms
Adolescent, Adult, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Metabolic Diseases, Middle Aged, Netherlands, Obesity, Phenotype, Polycystic Ovary Syndrome, Risk Factors, Comorbidity, Incidence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review